JP2015517566A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517566A5 JP2015517566A5 JP2015513334A JP2015513334A JP2015517566A5 JP 2015517566 A5 JP2015517566 A5 JP 2015517566A5 JP 2015513334 A JP2015513334 A JP 2015513334A JP 2015513334 A JP2015513334 A JP 2015513334A JP 2015517566 A5 JP2015517566 A5 JP 2015517566A5
- Authority
- JP
- Japan
- Prior art keywords
- chloro
- phenyl
- pyrrol
- isopropyl
- pyrrolo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 methoxyethyl- Chemical group 0.000 claims 103
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 30
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 20
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 17
- 150000001875 compounds Chemical class 0.000 claims 15
- 150000003839 salts Chemical class 0.000 claims 14
- 125000005843 halogen group Chemical group 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 claims 5
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 claims 4
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 claims 4
- 102000017274 MDM4 Human genes 0.000 claims 4
- 108050005300 MDM4 Proteins 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 3
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 230000001404 mediated effect Effects 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- INTJZENRAYCATA-UHFFFAOYSA-N pyrrol-3-one Chemical compound O=C1C=CN=C1 INTJZENRAYCATA-UHFFFAOYSA-N 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- FGPTWTSRUGMJDE-QKFKETGDSA-N (6r)-2-(2-amino-4-methoxypyrimidin-5-yl)-5-(3-chloro-4-fluorophenyl)-6-(4-chlorophenyl)-1-[(2r)-1-methoxypropan-2-yl]-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound C1([C@H]2N(C(=O)C=3C=C(N(C2=3)[C@H](C)COC)C=2C(=NC(N)=NC=2)OC)C=2C=C(Cl)C(F)=CC=2)=CC=C(Cl)C=C1 FGPTWTSRUGMJDE-QKFKETGDSA-N 0.000 claims 1
- QCKNGTYKLJBZHR-HSZRJFAPSA-N (6r)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chloro-2-methylphenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C(=CC(Cl)=CC=1)C)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O QCKNGTYKLJBZHR-HSZRJFAPSA-N 0.000 claims 1
- VTGDOFNBBBIIFU-JOCHJYFZSA-N (6r)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O VTGDOFNBBBIIFU-JOCHJYFZSA-N 0.000 claims 1
- VNOJIJITXHFGMF-MUUNZHRXSA-N (6r)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-6-methyl-1-propan-2-ylpyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@@](C)(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O VNOJIJITXHFGMF-MUUNZHRXSA-N 0.000 claims 1
- YZFOGCNKBSEULT-XMMPIXPASA-N (6r)-5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O YZFOGCNKBSEULT-XMMPIXPASA-N 0.000 claims 1
- QLTYTONTIBMGPM-JOCHJYFZSA-N (6r)-5-(5-chloro-6-oxo-1h-pyridin-3-yl)-6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(Cl)=CC=1)N(C=1C=C(Cl)C(=O)NC=1)C2=O QLTYTONTIBMGPM-JOCHJYFZSA-N 0.000 claims 1
- FGPTWTSRUGMJDE-FATZIPQQSA-N (6s)-2-(2-amino-4-methoxypyrimidin-5-yl)-5-(3-chloro-4-fluorophenyl)-6-(4-chlorophenyl)-1-[(2r)-1-methoxypropan-2-yl]-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound C1([C@@H]2N(C(=O)C=3C=C(N(C2=3)[C@H](C)COC)C=2C(=NC(N)=NC=2)OC)C=2C=C(Cl)C(F)=CC=2)=CC=C(Cl)C=C1 FGPTWTSRUGMJDE-FATZIPQQSA-N 0.000 claims 1
- QCKNGTYKLJBZHR-QHCPKHFHSA-N (6s)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chloro-2-methylphenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C(=CC(Cl)=CC=1)C)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O QCKNGTYKLJBZHR-QHCPKHFHSA-N 0.000 claims 1
- VTGDOFNBBBIIFU-QFIPXVFZSA-N (6s)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O VTGDOFNBBBIIFU-QFIPXVFZSA-N 0.000 claims 1
- VNOJIJITXHFGMF-NDEPHWFRSA-N (6s)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-6-methyl-1-propan-2-ylpyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@](C)(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O VNOJIJITXHFGMF-NDEPHWFRSA-N 0.000 claims 1
- YZFOGCNKBSEULT-DEOSSOPVSA-N (6s)-5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O YZFOGCNKBSEULT-DEOSSOPVSA-N 0.000 claims 1
- QLTYTONTIBMGPM-QFIPXVFZSA-N (6s)-5-(5-chloro-6-oxo-1h-pyridin-3-yl)-6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(Cl)=CC=1)N(C=1C=C(Cl)C(=O)NC=1)C2=O QLTYTONTIBMGPM-QFIPXVFZSA-N 0.000 claims 1
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 claims 1
- 125000006536 (C1-C2)alkoxy group Chemical group 0.000 claims 1
- PCYWMDGJYQAMCR-UHFFFAOYSA-N 1h-pyrrole-3-carbonitrile Chemical compound N#CC=1C=CNC=1 PCYWMDGJYQAMCR-UHFFFAOYSA-N 0.000 claims 1
- FFMAOIYFWDTUHY-UHFFFAOYSA-N 2-(2-amino-4-methoxypyrimidin-5-yl)-5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-6-(4-chlorophenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O FFMAOIYFWDTUHY-UHFFFAOYSA-N 0.000 claims 1
- HJPAMNFAEFPFAA-UHFFFAOYSA-N 2-(2-amino-4-methoxypyrimidin-5-yl)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chloro-2-methylphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)C)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O HJPAMNFAEFPFAA-UHFFFAOYSA-N 0.000 claims 1
- XMQRFSWKZVXRFN-UHFFFAOYSA-N 2-(2-amino-4-methoxypyrimidin-5-yl)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O XMQRFSWKZVXRFN-UHFFFAOYSA-N 0.000 claims 1
- YAORRZXEAIDLOS-UHFFFAOYSA-N 2-(2-amino-4-methoxypyrimidin-5-yl)-5-(5-chloro-2-methoxypyridin-3-yl)-6-(4-chlorophenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC=C(Cl)C=C1N1C(=O)C(C=C(C=2C(=NC(N)=NC=2)OC)N2C(C)C)=C2C1C1=CC=C(Cl)C=C1 YAORRZXEAIDLOS-UHFFFAOYSA-N 0.000 claims 1
- YMDJIUXSNMFBNK-UHFFFAOYSA-N 2-(2-amino-4-methoxypyrimidin-5-yl)-5-(5-chloro-6-oxo-1h-pyridin-3-yl)-6-(4-chlorophenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C=C(Cl)C(=O)NC=1)C2=O YMDJIUXSNMFBNK-UHFFFAOYSA-N 0.000 claims 1
- LXERHGYQVXUJRQ-UHFFFAOYSA-N 2-(2-amino-4-methoxypyrimidin-5-yl)-6-(4-chlorophenyl)-5-(2,5-dimethylpyrazol-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1N(N=C(C)C=1)C)C2=O LXERHGYQVXUJRQ-UHFFFAOYSA-N 0.000 claims 1
- SMIIJGLUXLTXPE-UHFFFAOYSA-N 2-(2-amino-4-methoxypyrimidin-5-yl)-6-(4-chlorophenyl)-5-(4-methoxycyclohexyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound C1CC(OC)CCC1N1C(=O)C(C=C(C=2C(=NC(N)=NC=2)OC)N2C(C)C)=C2C1C1=CC=C(Cl)C=C1 SMIIJGLUXLTXPE-UHFFFAOYSA-N 0.000 claims 1
- MUUZZGAMDJCACC-UHFFFAOYSA-N 2-(2-amino-4-methoxypyrimidin-5-yl)-6-(4-chlorophenyl)-5-(oxan-4-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1CCOCC1)C2=O MUUZZGAMDJCACC-UHFFFAOYSA-N 0.000 claims 1
- AKRDHGGMTLKLII-UHFFFAOYSA-N 2-[2-(2-amino-4-methoxypyrimidin-5-yl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-5-yl]-4-chlorobenzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C#N)C2=O AKRDHGGMTLKLII-UHFFFAOYSA-N 0.000 claims 1
- NBVBMZRUNBAPLX-GDLZYMKVSA-N 2-[3-[(6r)-5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxyphenyl]acetic acid Chemical compound COC1=CC=C(CC(O)=O)C=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O NBVBMZRUNBAPLX-GDLZYMKVSA-N 0.000 claims 1
- NBVBMZRUNBAPLX-LJAQVGFWSA-N 2-[3-[(6s)-5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxyphenyl]acetic acid Chemical compound COC1=CC=C(CC(O)=O)C=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O NBVBMZRUNBAPLX-LJAQVGFWSA-N 0.000 claims 1
- ZKXXUOFBGYBXBG-UHFFFAOYSA-N 2-[3-[5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxyphenyl]acetic acid Chemical compound COC1=CC=C(CC(O)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O ZKXXUOFBGYBXBG-UHFFFAOYSA-N 0.000 claims 1
- UWYJVUIKLPQQIR-UHFFFAOYSA-N 2-[3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxyphenyl]-n,n-dimethylacetamide Chemical compound COC1=CC=C(CC(=O)N(C)C)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O UWYJVUIKLPQQIR-UHFFFAOYSA-N 0.000 claims 1
- MVNVEOWYICDPQA-UHFFFAOYSA-N 2-[3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxyphenyl]-n-methylacetamide Chemical compound CNC(=O)CC1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C=2C(=CC=C(Cl)C=2)C)C=2C=CC(Cl)=CC=2)C(C)C)=C1 MVNVEOWYICDPQA-UHFFFAOYSA-N 0.000 claims 1
- WWHWAAJKQGGHIK-UHFFFAOYSA-N 2-[3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxyphenyl]acetamide Chemical compound COC1=CC=C(CC(N)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O WWHWAAJKQGGHIK-UHFFFAOYSA-N 0.000 claims 1
- NBVBMZRUNBAPLX-UHFFFAOYSA-N 2-[3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxyphenyl]acetic acid Chemical compound COC1=CC=C(CC(O)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O NBVBMZRUNBAPLX-UHFFFAOYSA-N 0.000 claims 1
- RUVPTRXOQQUJIP-UHFFFAOYSA-N 2-[4-[5-(3-chloro-2-fluorophenyl)-6-(4-cyanophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-5-methoxypyridin-2-yl]acetic acid Chemical compound COC1=CN=C(CC(O)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(=C(Cl)C=CC=1)F)C2=O RUVPTRXOQQUJIP-UHFFFAOYSA-N 0.000 claims 1
- ZVKVJRYUHUKSFD-UHFFFAOYSA-N 2-[5-[5-(3-chloro-2-fluorophenyl)-6-(4-cyanophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-6-methoxypyridin-3-yl]-n-methylacetamide Chemical compound CNC(=O)CC1=CN=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C=2C(=C(Cl)C=CC=2)F)C=2C=CC(=CC=2)C#N)C(C)C)=C1 ZVKVJRYUHUKSFD-UHFFFAOYSA-N 0.000 claims 1
- CJCXKFFSPDPEDJ-MUUNZHRXSA-N 3-[(6r)-5-(3-chloro-2-fluorophenyl)-6-(4-chloro-2-methylphenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3[C@H](N(C(=O)C=3C=2)C=2C(=C(Cl)C=CC=2)F)C=2C(=CC(Cl)=CC=2)C)C(C)C)=C1 CJCXKFFSPDPEDJ-MUUNZHRXSA-N 0.000 claims 1
- QIDROMJGYTVCCT-GDLZYMKVSA-N 3-[(6r)-5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n,n-dimethylbenzamide Chemical compound COC1=CC=C(C(=O)N(C)C)C=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O QIDROMJGYTVCCT-GDLZYMKVSA-N 0.000 claims 1
- NZQSMNSXZCVNDS-MUUNZHRXSA-N 3-[(6r)-5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3[C@H](N(C(=O)C=3C=2)C=2C(=CC=C(Cl)C=2)C)C=2C=CC(Cl)=CC=2)C(C)C)=C1 NZQSMNSXZCVNDS-MUUNZHRXSA-N 0.000 claims 1
- ILWFBBGNMHVGNM-HHHXNRCGSA-N 3-[(6r)-5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O ILWFBBGNMHVGNM-HHHXNRCGSA-N 0.000 claims 1
- JQUIAIKLJOCMEX-GDLZYMKVSA-N 3-[(6r)-6-(4-chloro-2-methylphenyl)-5-(5-chloro-2-methylphenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3[C@H](N(C(=O)C=3C=2)C=2C(=CC=C(Cl)C=2)C)C=2C(=CC(Cl)=CC=2)C)C(C)C)=C1 JQUIAIKLJOCMEX-GDLZYMKVSA-N 0.000 claims 1
- CJCXKFFSPDPEDJ-NDEPHWFRSA-N 3-[(6s)-5-(3-chloro-2-fluorophenyl)-6-(4-chloro-2-methylphenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3[C@@H](N(C(=O)C=3C=2)C=2C(=C(Cl)C=CC=2)F)C=2C(=CC(Cl)=CC=2)C)C(C)C)=C1 CJCXKFFSPDPEDJ-NDEPHWFRSA-N 0.000 claims 1
- QIDROMJGYTVCCT-LJAQVGFWSA-N 3-[(6s)-5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n,n-dimethylbenzamide Chemical compound COC1=CC=C(C(=O)N(C)C)C=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O QIDROMJGYTVCCT-LJAQVGFWSA-N 0.000 claims 1
- NZQSMNSXZCVNDS-NDEPHWFRSA-N 3-[(6s)-5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3[C@@H](N(C(=O)C=3C=2)C=2C(=CC=C(Cl)C=2)C)C=2C=CC(Cl)=CC=2)C(C)C)=C1 NZQSMNSXZCVNDS-NDEPHWFRSA-N 0.000 claims 1
- ILWFBBGNMHVGNM-MHZLTWQESA-N 3-[(6s)-5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O ILWFBBGNMHVGNM-MHZLTWQESA-N 0.000 claims 1
- JQUIAIKLJOCMEX-LJAQVGFWSA-N 3-[(6s)-6-(4-chloro-2-methylphenyl)-5-(5-chloro-2-methylphenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3[C@@H](N(C(=O)C=3C=2)C=2C(=CC=C(Cl)C=2)C)C=2C(=CC(Cl)=CC=2)C)C(C)C)=C1 JQUIAIKLJOCMEX-LJAQVGFWSA-N 0.000 claims 1
- CJCXKFFSPDPEDJ-UHFFFAOYSA-N 3-[5-(3-chloro-2-fluorophenyl)-6-(4-chloro-2-methylphenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C=2C(=C(Cl)C=CC=2)F)C=2C(=CC(Cl)=CC=2)C)C(C)C)=C1 CJCXKFFSPDPEDJ-UHFFFAOYSA-N 0.000 claims 1
- JVQOZXAGUFLHTP-UHFFFAOYSA-N 3-[5-(3-chloro-4-fluorophenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C=2C=C(Cl)C(F)=CC=2)C=2C=CC(Cl)=CC=2)C(C)C)=C1 JVQOZXAGUFLHTP-UHFFFAOYSA-N 0.000 claims 1
- AUCFWTPOSQPMCN-UHFFFAOYSA-N 3-[5-(3-chloro-4-fluorophenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C=C(Cl)C(F)=CC=1)C2=O AUCFWTPOSQPMCN-UHFFFAOYSA-N 0.000 claims 1
- LXTGXLSPSBMXFK-UHFFFAOYSA-N 3-[5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chloro-2-methylphenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C2=CN(C)C(=O)C(Cl)=C2)C=2C(=CC(Cl)=CC=2)C)C(C)C)=C1 LXTGXLSPSBMXFK-UHFFFAOYSA-N 0.000 claims 1
- AHKXWUMEVJBCEZ-UHFFFAOYSA-N 3-[5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C2=CN(C)C(=O)C(Cl)=C2)C=2C=CC(Cl)=CC=2)C(C)C)=C1 AHKXWUMEVJBCEZ-UHFFFAOYSA-N 0.000 claims 1
- ROQOHOOZYYGUFU-UHFFFAOYSA-N 3-[5-(5-chloro-2-cyanophenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C=2C(=CC=C(Cl)C=2)C#N)C=2C=CC(Cl)=CC=2)C(C)C)=C1 ROQOHOOZYYGUFU-UHFFFAOYSA-N 0.000 claims 1
- QIDROMJGYTVCCT-UHFFFAOYSA-N 3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n,n-dimethylbenzamide Chemical compound COC1=CC=C(C(=O)N(C)C)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O QIDROMJGYTVCCT-UHFFFAOYSA-N 0.000 claims 1
- POZXFZSLKQZFDU-UHFFFAOYSA-N 3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-(2-methylsulfonylethyl)benzamide Chemical compound COC1=CC=C(C(=O)NCCS(C)(=O)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O POZXFZSLKQZFDU-UHFFFAOYSA-N 0.000 claims 1
- NZQSMNSXZCVNDS-UHFFFAOYSA-N 3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C=2C(=CC=C(Cl)C=2)C)C=2C=CC(Cl)=CC=2)C(C)C)=C1 NZQSMNSXZCVNDS-UHFFFAOYSA-N 0.000 claims 1
- YYXIJDCSNCCYED-UHFFFAOYSA-N 3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C=2C(=CC=C(Cl)C=2)C)C=2C=CC(Cl)=CC=2)C(C)C)=C1 YYXIJDCSNCCYED-UHFFFAOYSA-N 0.000 claims 1
- ZFWNPUCAIBBZKA-UHFFFAOYSA-N 3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxybenzamide Chemical compound COC1=CC=C(C(N)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O ZFWNPUCAIBBZKA-UHFFFAOYSA-N 0.000 claims 1
- ILWFBBGNMHVGNM-UHFFFAOYSA-N 3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O ILWFBBGNMHVGNM-UHFFFAOYSA-N 0.000 claims 1
- CNUKBVSXXVSKRM-UHFFFAOYSA-N 3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxybenzonitrile Chemical compound COC1=CC=C(C#N)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O CNUKBVSXXVSKRM-UHFFFAOYSA-N 0.000 claims 1
- MQCHZUMQAXKSCI-UHFFFAOYSA-N 3-[5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-n-(2-hydroxyethoxy)-4-methoxybenzamide Chemical compound COC1=CC=C(C(=O)NOCCO)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O MQCHZUMQAXKSCI-UHFFFAOYSA-N 0.000 claims 1
- JQUIAIKLJOCMEX-UHFFFAOYSA-N 3-[6-(4-chloro-2-methylphenyl)-5-(5-chloro-2-methylphenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C=2C(=CC=C(Cl)C=2)C)C=2C(=CC(Cl)=CC=2)C)C(C)C)=C1 JQUIAIKLJOCMEX-UHFFFAOYSA-N 0.000 claims 1
- HQBBVDYAGQBRER-UHFFFAOYSA-N 3-[6-(4-chlorophenyl)-5-(oxan-4-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C2CCOCC2)C=2C=CC(Cl)=CC=2)C(C)C)=C1 HQBBVDYAGQBRER-UHFFFAOYSA-N 0.000 claims 1
- RDPVPQKEQQLYDA-UHFFFAOYSA-N 3-[6-(4-chlorophenyl)-5-(oxan-4-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-4-methoxybenzonitrile Chemical compound COC1=CC=C(C#N)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1CCOCC1)C2=O RDPVPQKEQQLYDA-UHFFFAOYSA-N 0.000 claims 1
- RNNIMJVUCFVPIR-HSZRJFAPSA-N 4-[(6r)-2-(2-amino-4-methoxypyrimidin-5-yl)-5-(3-chloro-2-fluorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(=CC=1)C#N)N(C=1C(=C(Cl)C=CC=1)F)C2=O RNNIMJVUCFVPIR-HSZRJFAPSA-N 0.000 claims 1
- WDNMFYATUPBESP-HSZRJFAPSA-N 4-[(6r)-2-(2-amino-4-methoxypyrimidin-5-yl)-5-(3-chloro-4-fluorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(=CC=1)C#N)N(C=1C=C(Cl)C(F)=CC=1)C2=O WDNMFYATUPBESP-HSZRJFAPSA-N 0.000 claims 1
- WFWTZNXJCNYUAQ-XMMPIXPASA-N 4-[(6r)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-5-(oxan-4-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(=CC=1)C#N)N(C1CCOCC1)C2=O WFWTZNXJCNYUAQ-XMMPIXPASA-N 0.000 claims 1
- HHNKSOUSJFWEBC-RUZDIDTESA-N 4-[(6r)-5-(3-chloro-4-fluorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(=CC=1)C#N)N(C=1C=C(Cl)C(F)=CC=1)C2=O HHNKSOUSJFWEBC-RUZDIDTESA-N 0.000 claims 1
- BTRWWPFRLVLFAI-HSZRJFAPSA-N 4-[(6r)-5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(=CC=1)C#N)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O BTRWWPFRLVLFAI-HSZRJFAPSA-N 0.000 claims 1
- FIXFXNNSCCMJIC-HSZRJFAPSA-N 4-[(6r)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]-2-fluorobenzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=C(F)C(C#N)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O FIXFXNNSCCMJIC-HSZRJFAPSA-N 0.000 claims 1
- AMVOKCMSEMEARJ-HSZRJFAPSA-N 4-[(6r)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(=CC=1)C#N)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O AMVOKCMSEMEARJ-HSZRJFAPSA-N 0.000 claims 1
- LXWPKTFVYXPXGO-XMMPIXPASA-N 4-[(6r)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1[C@@H](C=1C=CC(=CC=1)C#N)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O LXWPKTFVYXPXGO-XMMPIXPASA-N 0.000 claims 1
- RNNIMJVUCFVPIR-QHCPKHFHSA-N 4-[(6s)-2-(2-amino-4-methoxypyrimidin-5-yl)-5-(3-chloro-2-fluorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(=CC=1)C#N)N(C=1C(=C(Cl)C=CC=1)F)C2=O RNNIMJVUCFVPIR-QHCPKHFHSA-N 0.000 claims 1
- WDNMFYATUPBESP-QHCPKHFHSA-N 4-[(6s)-2-(2-amino-4-methoxypyrimidin-5-yl)-5-(3-chloro-4-fluorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(=CC=1)C#N)N(C=1C=C(Cl)C(F)=CC=1)C2=O WDNMFYATUPBESP-QHCPKHFHSA-N 0.000 claims 1
- WFWTZNXJCNYUAQ-DEOSSOPVSA-N 4-[(6s)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-5-(oxan-4-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(=CC=1)C#N)N(C1CCOCC1)C2=O WFWTZNXJCNYUAQ-DEOSSOPVSA-N 0.000 claims 1
- HHNKSOUSJFWEBC-VWLOTQADSA-N 4-[(6s)-5-(3-chloro-4-fluorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(=CC=1)C#N)N(C=1C=C(Cl)C(F)=CC=1)C2=O HHNKSOUSJFWEBC-VWLOTQADSA-N 0.000 claims 1
- BTRWWPFRLVLFAI-QHCPKHFHSA-N 4-[(6s)-5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(=CC=1)C#N)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O BTRWWPFRLVLFAI-QHCPKHFHSA-N 0.000 claims 1
- FIXFXNNSCCMJIC-QHCPKHFHSA-N 4-[(6s)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]-2-fluorobenzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=C(F)C(C#N)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O FIXFXNNSCCMJIC-QHCPKHFHSA-N 0.000 claims 1
- LXWPKTFVYXPXGO-DEOSSOPVSA-N 4-[(6s)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1[C@H](C=1C=CC(=CC=1)C#N)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O LXWPKTFVYXPXGO-DEOSSOPVSA-N 0.000 claims 1
- SYFLQGBLVFJSKU-UHFFFAOYSA-N 4-[2-(2,4-dimethoxypyrimidin-5-yl)-5-(2,5-dimethylpyrazol-3-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1N(N=C(C)C=1)C)C2=O SYFLQGBLVFJSKU-UHFFFAOYSA-N 0.000 claims 1
- QUNXWDFSYHBUTD-UHFFFAOYSA-N 4-[2-(2,4-dimethoxypyrimidin-5-yl)-5-(4-fluoro-2,5-dimethylpyrazol-3-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1N(N=C(C)C=1F)C)C2=O QUNXWDFSYHBUTD-UHFFFAOYSA-N 0.000 claims 1
- CLJJHBGCJSNWAQ-UHFFFAOYSA-N 4-[2-(2,4-dimethoxypyrimidin-5-yl)-5-(4-hydroxycyclohexyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C1CCC(O)CC1)C2=O CLJJHBGCJSNWAQ-UHFFFAOYSA-N 0.000 claims 1
- JIASIEBVVKDQSA-UHFFFAOYSA-N 4-[2-(2,4-dimethoxypyrimidin-5-yl)-5-(oxan-4-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C1CCOCC1)C2=O JIASIEBVVKDQSA-UHFFFAOYSA-N 0.000 claims 1
- RNNIMJVUCFVPIR-UHFFFAOYSA-N 4-[2-(2-amino-4-methoxypyrimidin-5-yl)-5-(3-chloro-2-fluorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(=C(Cl)C=CC=1)F)C2=O RNNIMJVUCFVPIR-UHFFFAOYSA-N 0.000 claims 1
- WDNMFYATUPBESP-UHFFFAOYSA-N 4-[2-(2-amino-4-methoxypyrimidin-5-yl)-5-(3-chloro-4-fluorophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C=C(Cl)C(F)=CC=1)C2=O WDNMFYATUPBESP-UHFFFAOYSA-N 0.000 claims 1
- VFRZUQFKLVXGLO-UHFFFAOYSA-N 4-[2-(2-amino-4-methoxypyrimidin-5-yl)-5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O VFRZUQFKLVXGLO-UHFFFAOYSA-N 0.000 claims 1
- KWIUQJKKCSQXRV-UHFFFAOYSA-N 4-[2-(2-amino-4-methoxypyrimidin-5-yl)-5-(5-chloro-2-methylphenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(=CC=C(Cl)C=1)C)C2=O KWIUQJKKCSQXRV-UHFFFAOYSA-N 0.000 claims 1
- BQOVCZLIKRCFMV-UHFFFAOYSA-N 4-[2-(2-amino-4-methoxypyrimidin-5-yl)-5-(5-chloro-2-oxo-1h-pyridin-3-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(NC=C(Cl)C=1)=O)C2=O BQOVCZLIKRCFMV-UHFFFAOYSA-N 0.000 claims 1
- DICXGXCOOQDAHS-UHFFFAOYSA-N 4-[2-(2-amino-4-methoxypyrimidin-5-yl)-5-(5-chloro-6-oxo-1h-pyridin-3-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C=C(Cl)C(=O)NC=1)C2=O DICXGXCOOQDAHS-UHFFFAOYSA-N 0.000 claims 1
- XBEOBDCKLAOUOT-UHFFFAOYSA-N 4-[2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-5-(2,5-dimethylpyrazol-3-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1N(N=C(C)C=1)C)C2=O XBEOBDCKLAOUOT-UHFFFAOYSA-N 0.000 claims 1
- QWPLMSVDELZPDN-UHFFFAOYSA-N 4-[2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-5-(4-fluoro-2,5-dimethylpyrazol-3-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1N(N=C(C)C=1F)C)C2=O QWPLMSVDELZPDN-UHFFFAOYSA-N 0.000 claims 1
- BYRJUTKQELDTHA-UHFFFAOYSA-N 4-[5-(3-chloro-2-fluorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(=C(Cl)C=CC=1)F)C2=O BYRJUTKQELDTHA-UHFFFAOYSA-N 0.000 claims 1
- RWYNHMVMXJDBQA-UHFFFAOYSA-N 4-[5-(3-chloro-2-fluorophenyl)-2-[2-(cyanomethyl)-5-methoxypyridin-4-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=CN=C(CC#N)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(=C(Cl)C=CC=1)F)C2=O RWYNHMVMXJDBQA-UHFFFAOYSA-N 0.000 claims 1
- FIEMMYXPWCYUGL-UHFFFAOYSA-N 4-[5-(3-chloro-2-fluorophenyl)-2-[5-(cyanomethyl)-2-methoxypyridin-3-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC=C(CC#N)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(=C(Cl)C=CC=1)F)C2=O FIEMMYXPWCYUGL-UHFFFAOYSA-N 0.000 claims 1
- MIVOCHUDXRPWHQ-UHFFFAOYSA-N 4-[5-(3-chloro-4-fluorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C=C(Cl)C(F)=CC=1)C2=O MIVOCHUDXRPWHQ-UHFFFAOYSA-N 0.000 claims 1
- ONYWYNWVPOSRNR-UHFFFAOYSA-N 4-[5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]-2-fluorobenzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=C(F)C(C#N)=CC=1)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O ONYWYNWVPOSRNR-UHFFFAOYSA-N 0.000 claims 1
- BTRWWPFRLVLFAI-UHFFFAOYSA-N 4-[5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O BTRWWPFRLVLFAI-UHFFFAOYSA-N 0.000 claims 1
- QKOFNLDIMVQPMB-UHFFFAOYSA-N 4-[5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-2-[4-methoxy-2-(methylamino)pyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(NC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O QKOFNLDIMVQPMB-UHFFFAOYSA-N 0.000 claims 1
- FIXFXNNSCCMJIC-UHFFFAOYSA-N 4-[5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]-2-fluorobenzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=C(F)C(C#N)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O FIXFXNNSCCMJIC-UHFFFAOYSA-N 0.000 claims 1
- AMVOKCMSEMEARJ-UHFFFAOYSA-N 4-[5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O AMVOKCMSEMEARJ-UHFFFAOYSA-N 0.000 claims 1
- GKIWBJRVFITOEZ-UHFFFAOYSA-N 4-[5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-2-(4-methoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O GKIWBJRVFITOEZ-UHFFFAOYSA-N 0.000 claims 1
- QQLGWDCSGRNUFW-UHFFFAOYSA-N 4-[5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-2-[4-methoxy-2-(methylamino)pyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(NC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O QQLGWDCSGRNUFW-UHFFFAOYSA-N 0.000 claims 1
- SERCQBDCEWXGLC-UHFFFAOYSA-N 4-[5-(5-chloro-2-methoxypyridin-3-yl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC=C(Cl)C=C1N1C(=O)C(C=C(C=2C(=NC(=NC=2)N(C)C)OC)N2C(C)C)=C2C1C1=CC=C(C#N)C=C1 SERCQBDCEWXGLC-UHFFFAOYSA-N 0.000 claims 1
- CVUUVHAYWBQSNU-UHFFFAOYSA-N 4-[5-(5-chloro-2-oxo-1h-pyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]-2-fluorobenzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=C(F)C(C#N)=CC=1)N(C=1C(NC=C(Cl)C=1)=O)C2=O CVUUVHAYWBQSNU-UHFFFAOYSA-N 0.000 claims 1
- XTAZIILNJPYNBS-UHFFFAOYSA-N 4-[5-(5-chloro-2-oxo-1h-pyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(NC=C(Cl)C=1)=O)C2=O XTAZIILNJPYNBS-UHFFFAOYSA-N 0.000 claims 1
- UJPXDELIPFIVRI-UHFFFAOYSA-N 4-[5-(5-chloro-2-oxo-1h-pyridin-3-yl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]-2-fluorobenzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=C(F)C(C#N)=CC=1)N(C=1C(NC=C(Cl)C=1)=O)C2=O UJPXDELIPFIVRI-UHFFFAOYSA-N 0.000 claims 1
- MBCRUKORVFBRLW-UHFFFAOYSA-N 4-[5-(5-chloro-2-oxo-1h-pyridin-3-yl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C(NC=C(Cl)C=1)=O)C2=O MBCRUKORVFBRLW-UHFFFAOYSA-N 0.000 claims 1
- NIMGHWDAHLRYOC-UHFFFAOYSA-N 4-[5-(5-chloro-6-oxo-1h-pyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C=C(Cl)C(=O)NC=1)C2=O NIMGHWDAHLRYOC-UHFFFAOYSA-N 0.000 claims 1
- NSVAVIHHMMLAIR-UHFFFAOYSA-N 4-[5-(5-chloro-6-oxo-1h-pyridin-3-yl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(=CC=1)C#N)N(C=1C=C(Cl)C(=O)NC=1)C2=O NSVAVIHHMMLAIR-UHFFFAOYSA-N 0.000 claims 1
- FSAYSWYPULVFEH-UHFFFAOYSA-N 4-[6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-5-yl]-n-methylpiperidine-1-carboxamide Chemical compound C1CN(C(=O)NC)CCC1N1C(=O)C(C=C(C=2C(=NC(OC)=NC=2)OC)N2C(C)C)=C2C1C1=CC=C(Cl)C=C1 FSAYSWYPULVFEH-UHFFFAOYSA-N 0.000 claims 1
- AKWZPUSKVCENQN-UHFFFAOYSA-N 4-chloro-2-[6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-5-yl]benzonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C#N)C2=O AKWZPUSKVCENQN-UHFFFAOYSA-N 0.000 claims 1
- BMYHCCBUUIQXSX-UHFFFAOYSA-N 4-chloro-2-[6-(4-chlorophenyl)-2-(2-methoxyphenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-5-yl]benzonitrile Chemical compound COC1=CC=CC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C#N)C2=O BMYHCCBUUIQXSX-UHFFFAOYSA-N 0.000 claims 1
- KEWDJHXGSOLCJT-UHFFFAOYSA-N 4-chloro-2-[6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-5-yl]benzonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C#N)C2=O KEWDJHXGSOLCJT-UHFFFAOYSA-N 0.000 claims 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 1
- HPUAUMBBZXSYGE-UHFFFAOYSA-N 5-(3-chloro-2-fluorophenyl)-6-(4-chloro-2-methylphenyl)-2-(2-methoxyphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=CC=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)C)N(C=1C(=C(Cl)C=CC=1)F)C2=O HPUAUMBBZXSYGE-UHFFFAOYSA-N 0.000 claims 1
- ARJOFOSCVBNMBI-UHFFFAOYSA-N 5-(3-chloro-2-fluorophenyl)-6-(4-chloro-2-methylphenyl)-2-(2-methoxypyridin-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC=CC=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)C)N(C=1C(=C(Cl)C=CC=1)F)C2=O ARJOFOSCVBNMBI-UHFFFAOYSA-N 0.000 claims 1
- XFXHIRDFHWUYQO-UHFFFAOYSA-N 5-(3-chloro-2-fluorophenyl)-6-(4-chloro-2-methylphenyl)-2-[5-(hydroxymethyl)-2-methoxyphenyl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=C(CO)C=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)C)N(C=1C(=C(Cl)C=CC=1)F)C2=O XFXHIRDFHWUYQO-UHFFFAOYSA-N 0.000 claims 1
- MPTBXFFUCNMTKA-UHFFFAOYSA-N 5-(3-chloro-2-fluorophenyl)-6-(5-chloropyridin-2-yl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1N=CC(Cl)=CC=1)N(C=1C(=C(Cl)C=CC=1)F)C2=O MPTBXFFUCNMTKA-UHFFFAOYSA-N 0.000 claims 1
- LEBMQPMVEIWNHI-UHFFFAOYSA-N 5-(3-chloro-4-fluorophenyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C=C(Cl)C(F)=CC=1)C2=O LEBMQPMVEIWNHI-UHFFFAOYSA-N 0.000 claims 1
- PHRQUZMQZUQZPF-UHFFFAOYSA-N 5-(3-chloro-4-fluorophenyl)-6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C=C(Cl)C(F)=CC=1)C2=O PHRQUZMQZUQZPF-UHFFFAOYSA-N 0.000 claims 1
- GHPMCAZUJDDVPG-UHFFFAOYSA-N 5-(3-chloro-4-fluorophenyl)-6-(4-chlorophenyl)-2-[2-methoxy-5-(morpholine-4-carbonyl)phenyl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=C(C(=O)N2CCOCC2)C=C1C(N(C=12)C(C)C)=CC=1C(=O)N(C=1C=C(Cl)C(F)=CC=1)C2C1=CC=C(Cl)C=C1 GHPMCAZUJDDVPG-UHFFFAOYSA-N 0.000 claims 1
- WDEVSGDQMMXJMI-UHFFFAOYSA-N 5-(3-chloro-4-fluorophenyl)-6-(5-chloropyridin-2-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1N=CC(Cl)=CC=1)N(C=1C=C(Cl)C(F)=CC=1)C2=O WDEVSGDQMMXJMI-UHFFFAOYSA-N 0.000 claims 1
- KNQQFNGEUDEPOZ-UHFFFAOYSA-N 5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O KNQQFNGEUDEPOZ-UHFFFAOYSA-N 0.000 claims 1
- UWBRSLULKRVRMT-UHFFFAOYSA-N 5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O UWBRSLULKRVRMT-UHFFFAOYSA-N 0.000 claims 1
- DNCDUYWFCAADAX-UHFFFAOYSA-N 5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-6-(5-chloropyridin-2-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1N=CC(Cl)=CC=1)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O DNCDUYWFCAADAX-UHFFFAOYSA-N 0.000 claims 1
- QCKNGTYKLJBZHR-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chloro-2-methylphenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)C)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O QCKNGTYKLJBZHR-UHFFFAOYSA-N 0.000 claims 1
- HYXMIUVZKIAVKS-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chloro-2-methylphenyl)-2-(2-methoxyphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=CC=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)C)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O HYXMIUVZKIAVKS-UHFFFAOYSA-N 0.000 claims 1
- UVZVOLBDFRAZEU-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chloro-2-methylphenyl)-2-[4-methoxy-2-(methylamino)pyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(NC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)C)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O UVZVOLBDFRAZEU-UHFFFAOYSA-N 0.000 claims 1
- KHHVQYZNIIFFOF-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-1-cyclopropyl-2-(2,4-dimethoxypyrimidin-5-yl)-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C2CC2)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O KHHVQYZNIIFFOF-UHFFFAOYSA-N 0.000 claims 1
- JQQVMAOZGKLNKN-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-1-cyclopropyl-2-(2-methoxypyrimidin-5-yl)-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound C1=NC(OC)=NC=C1C(N1C2CC2)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O JQQVMAOZGKLNKN-UHFFFAOYSA-N 0.000 claims 1
- VTGDOFNBBBIIFU-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O VTGDOFNBBBIIFU-UHFFFAOYSA-N 0.000 claims 1
- OWVWJRURQNSUGV-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrole-3-carbonitrile Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=C(C#N)C2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O OWVWJRURQNSUGV-UHFFFAOYSA-N 0.000 claims 1
- JWGZWGSFNVRFOS-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrole-3-carboxylic acid Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=C(C(O)=O)C2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O JWGZWGSFNVRFOS-UHFFFAOYSA-N 0.000 claims 1
- VNOJIJITXHFGMF-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-6-methyl-1-propan-2-ylpyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C)(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O VNOJIJITXHFGMF-UHFFFAOYSA-N 0.000 claims 1
- YOEKVFPZVBQFQS-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2-methoxy-5-methylsulfonylphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=C(S(C)(=O)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O YOEKVFPZVBQFQS-UHFFFAOYSA-N 0.000 claims 1
- UOITXPOYFHJLDG-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O UOITXPOYFHJLDG-UHFFFAOYSA-N 0.000 claims 1
- LNDKLOVDDSDBLX-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrole-3-carbonitrile Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=C(C#N)C2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O LNDKLOVDDSDBLX-UHFFFAOYSA-N 0.000 claims 1
- QFLQQPWYSVBNNV-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrole-3-carboxylic acid Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=C(C(O)=O)C2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O QFLQQPWYSVBNNV-UHFFFAOYSA-N 0.000 claims 1
- OWBQSHUGYPCMPH-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-[2-methoxy-5-(morpholine-4-carbonyl)phenyl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=C(C(=O)N2CCOCC2)C=C1C(N(C=12)C(C)C)=CC=1C(=O)N(C1=CN(C)C(=O)C(Cl)=C1)C2C1=CC=C(Cl)C=C1 OWBQSHUGYPCMPH-UHFFFAOYSA-N 0.000 claims 1
- ZIOTTXTYAJXBOJ-UHFFFAOYSA-N 5-(5-chloro-2-fluoro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1=C(N(C)C(=O)C(Cl)=C1)F)C2=O ZIOTTXTYAJXBOJ-UHFFFAOYSA-N 0.000 claims 1
- MIEMYVCLDZMUGL-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxyphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC(OC)=CC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O MIEMYVCLDZMUGL-UHFFFAOYSA-N 0.000 claims 1
- ZULSNYQIJDALQK-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-ethyl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound C1=2N(CC)C(C=3C(=NC(OC)=NC=3)OC)=CC=2C(=O)N(C=2C(=CC=C(Cl)C=2)C)C1C1=CC=C(Cl)C=C1 ZULSNYQIJDALQK-UHFFFAOYSA-N 0.000 claims 1
- YZFOGCNKBSEULT-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O YZFOGCNKBSEULT-UHFFFAOYSA-N 0.000 claims 1
- CQNLQGGJXSRPQH-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(2-hydroxyphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound C1=2N(C(C)C)C(C=3C(=CC=CC=3)O)=CC=2C(=O)N(C=2C(=CC=C(Cl)C=2)C)C1C1=CC=C(Cl)C=C1 CQNLQGGJXSRPQH-UHFFFAOYSA-N 0.000 claims 1
- MTEVACWRYGNEMB-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(2-methoxy-5-methylsulfonylphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=C(S(C)(=O)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O MTEVACWRYGNEMB-UHFFFAOYSA-N 0.000 claims 1
- SOSFGAIKFDNWDG-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(2-methoxyphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=CC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O SOSFGAIKFDNWDG-UHFFFAOYSA-N 0.000 claims 1
- GSQJRMZJYWCMON-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(2-methoxyphenyl)-6-methyl-1-propan-2-ylpyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=CC=C1C(N1C(C)C)=CC2=C1C(C)(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O GSQJRMZJYWCMON-UHFFFAOYSA-N 0.000 claims 1
- ZONHALRZIXAYGO-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(2-methoxypyridin-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC=CC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O ZONHALRZIXAYGO-UHFFFAOYSA-N 0.000 claims 1
- DYHDRBWGUXTIKZ-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(3-methoxypyridin-2-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=CN=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O DYHDRBWGUXTIKZ-UHFFFAOYSA-N 0.000 claims 1
- VWIUKUSNMLAMJQ-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(4-methoxypyridin-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O VWIUKUSNMLAMJQ-UHFFFAOYSA-N 0.000 claims 1
- BGPLNPYJPVUTME-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(4-methoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O BGPLNPYJPVUTME-UHFFFAOYSA-N 0.000 claims 1
- VTKBAGBSUMWTNK-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-(5-methoxy-1-methyl-2-oxopyridin-4-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CN(C)C(=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O VTKBAGBSUMWTNK-UHFFFAOYSA-N 0.000 claims 1
- DNEFBCBMSAPCFE-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O DNEFBCBMSAPCFE-UHFFFAOYSA-N 0.000 claims 1
- QNZXLWQESPUDAO-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-[2-methoxy-5-(2h-tetrazol-5-yl)phenyl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=C(C=2NN=NN=2)C=C1C(N(C=12)C(C)C)=CC=1C(=O)N(C=1C(=CC=C(Cl)C=1)C)C2C1=CC=C(Cl)C=C1 QNZXLWQESPUDAO-UHFFFAOYSA-N 0.000 claims 1
- NYQAJUIGTPVQJO-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-[2-methoxy-5-(morpholine-4-carbonyl)phenyl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=C(C(=O)N2CCOCC2)C=C1C(N(C=12)C(C)C)=CC=1C(=O)N(C=1C(=CC=C(Cl)C=1)C)C2C1=CC=C(Cl)C=C1 NYQAJUIGTPVQJO-UHFFFAOYSA-N 0.000 claims 1
- KXYHQCTWNZRFPA-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-[4-methoxy-2-(methylamino)pyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(NC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O KXYHQCTWNZRFPA-UHFFFAOYSA-N 0.000 claims 1
- CZSKBJUIZZVJCA-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-2-[5-(hydroxymethyl)-2-methoxyphenyl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=C(CO)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O CZSKBJUIZZVJCA-UHFFFAOYSA-N 0.000 claims 1
- MDUZDRLEWCSTAN-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(4-chlorophenyl)-3-fluoro-2-(2-methoxyphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=CC=C1C(N1C(C)C)=C(F)C2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O MDUZDRLEWCSTAN-UHFFFAOYSA-N 0.000 claims 1
- HVCBSSBUIPONLC-UHFFFAOYSA-N 5-(5-chloro-2-methylphenyl)-6-(5-chloropyridin-2-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1N=CC(Cl)=CC=1)N(C=1C(=CC=C(Cl)C=1)C)C2=O HVCBSSBUIPONLC-UHFFFAOYSA-N 0.000 claims 1
- IINPVBUJBKIHAS-UHFFFAOYSA-N 5-(5-chloro-2-oxo-1h-pyridin-3-yl)-6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(NC=C(Cl)C=1)=O)C2=O IINPVBUJBKIHAS-UHFFFAOYSA-N 0.000 claims 1
- QLTYTONTIBMGPM-UHFFFAOYSA-N 5-(5-chloro-6-oxo-1h-pyridin-3-yl)-6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C=C(Cl)C(=O)NC=1)C2=O QLTYTONTIBMGPM-UHFFFAOYSA-N 0.000 claims 1
- YOVBMDGCLOZVGS-UHFFFAOYSA-N 6-(4-chloro-2-fluorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-5-(2,5-dimethylpyrazol-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)F)N(C=1N(N=C(C)C=1)C)C2=O YOVBMDGCLOZVGS-UHFFFAOYSA-N 0.000 claims 1
- OSLNVLCEPCZWRC-UHFFFAOYSA-N 6-(4-chloro-2-methylphenyl)-2-(2-methoxyphenyl)-5-(oxan-4-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=CC=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)C)N(C1CCOCC1)C2=O OSLNVLCEPCZWRC-UHFFFAOYSA-N 0.000 claims 1
- BLEVOLXKWGTFKI-UHFFFAOYSA-N 6-(4-chloro-2-methylphenyl)-5-(4-hydroxycyclohexyl)-2-(2-methoxyphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=CC=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)C)N(C1CCC(O)CC1)C2=O BLEVOLXKWGTFKI-UHFFFAOYSA-N 0.000 claims 1
- FKLVAGWTFKZMIT-UHFFFAOYSA-N 6-(4-chloro-2-methylphenyl)-5-(5-chloro-2-methylphenyl)-2-(2-methoxyphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=CC=C1C(N1C(C)C)=CC2=C1C(C=1C(=CC(Cl)=CC=1)C)N(C=1C(=CC=C(Cl)C=1)C)C2=O FKLVAGWTFKZMIT-UHFFFAOYSA-N 0.000 claims 1
- SSZVBEVGRVJGSK-UHFFFAOYSA-N 6-(4-chloro-3-fluorophenyl)-5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=C(F)C(Cl)=CC=1)N(C=1C(N(C)C=C(Cl)C=1)=O)C2=O SSZVBEVGRVJGSK-UHFFFAOYSA-N 0.000 claims 1
- UUJYUPBVANTWFC-UHFFFAOYSA-N 6-(4-chloro-3-fluorophenyl)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=C(F)C(Cl)=CC=1)N(C1=CN(C)C(=O)C(Cl)=C1)C2=O UUJYUPBVANTWFC-UHFFFAOYSA-N 0.000 claims 1
- FPQXODWXDOVXLT-UHFFFAOYSA-N 6-(4-chloro-3-fluorophenyl)-5-(5-chloro-2-oxo-1h-pyridin-3-yl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=C(F)C(Cl)=CC=1)N(C=1C(NC=C(Cl)C=1)=O)C2=O FPQXODWXDOVXLT-UHFFFAOYSA-N 0.000 claims 1
- ZPXHPYUSYJONRA-UHFFFAOYSA-N 6-(4-chloro-3-fluorophenyl)-5-(5-chloro-2-oxo-1h-pyridin-3-yl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=C(F)C(Cl)=CC=1)N(C=1C(NC=C(Cl)C=1)=O)C2=O ZPXHPYUSYJONRA-UHFFFAOYSA-N 0.000 claims 1
- OLPKXDUPEZNXEA-UHFFFAOYSA-N 6-(4-chlorophenyl)-1-cyclopropyl-2-(2,4-dimethoxypyrimidin-5-yl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C2CC2)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1=CN(C)C(=O)C(C)=C1)C2=O OLPKXDUPEZNXEA-UHFFFAOYSA-N 0.000 claims 1
- IRTOHFGPHMCDRK-UHFFFAOYSA-N 6-(4-chlorophenyl)-1-cyclopropyl-5-(1,5-dimethyl-6-oxopyridin-3-yl)-2-(1-methyl-2-oxopyridin-4-yl)-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound CN1C(=O)C(C)=CC(N2C(C3=C(N(C(C4=CC(=O)N(C)C=C4)=C3)C3CC3)C2C=2C=CC(Cl)=CC=2)=O)=C1 IRTOHFGPHMCDRK-UHFFFAOYSA-N 0.000 claims 1
- JQBLJMJODXODCK-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-5-(1,3-dimethyl-2-oxo-1,3-diazinan-5-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1CN(C)C(=O)N(C)C1)C2=O JQBLJMJODXODCK-UHFFFAOYSA-N 0.000 claims 1
- ACKYWAVUACZTMI-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-5-(1,3-dimethylpyrazol-4-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=NN(C)C=1)C)C2=O ACKYWAVUACZTMI-UHFFFAOYSA-N 0.000 claims 1
- XDFAMIIGZNGFSG-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-5-(1,5-dimethyl-2-oxopyridin-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(N(C)C=C(C)C=1)=O)C2=O XDFAMIIGZNGFSG-UHFFFAOYSA-N 0.000 claims 1
- HWKSKTWPKRZFEQ-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-5-(1-methyl-6-oxopiperidin-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1CN(C)C(=O)CC1)C2=O HWKSKTWPKRZFEQ-UHFFFAOYSA-N 0.000 claims 1
- WMFVQJAVWMCEBZ-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-5-(2,5-dimethylpyrazol-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1N(N=C(C)C=1)C)C2=O WMFVQJAVWMCEBZ-UHFFFAOYSA-N 0.000 claims 1
- FHLPGBPCEZAARR-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-5-(oxan-4-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1CCOCC1)C2=O FHLPGBPCEZAARR-UHFFFAOYSA-N 0.000 claims 1
- MMDOZNCKVZBKSH-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-5-piperidin-4-yl-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1CCNCC1)C2=O MMDOZNCKVZBKSH-UHFFFAOYSA-N 0.000 claims 1
- VARROHUFPFRARO-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-5-(1,3-dimethylpyrazol-4-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=NN(C)C=1)C)C2=O VARROHUFPFRARO-UHFFFAOYSA-N 0.000 claims 1
- DZVVZBDVIPZGIS-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-5-(1,4-dimethyl-6-oxopyridin-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=CC(=O)N(C)C=1)C)C2=O DZVVZBDVIPZGIS-UHFFFAOYSA-N 0.000 claims 1
- PEACFZXEMOIJCG-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-5-(2,5-dimethylpyrazol-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1N(N=C(C)C=1)C)C2=O PEACFZXEMOIJCG-UHFFFAOYSA-N 0.000 claims 1
- KHDQYDXGQQQGTO-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-5-(4-fluoro-2,5-dimethylpyrazol-3-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1N(N=C(C)C=1F)C)C2=O KHDQYDXGQQQGTO-UHFFFAOYSA-N 0.000 claims 1
- HHYGXPAFFFIANZ-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-[2-(dimethylamino)-4-methoxypyrimidin-5-yl]-5-(oxan-4-yl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C1CCOCC1)C2=O HHYGXPAFFFIANZ-UHFFFAOYSA-N 0.000 claims 1
- QIDDUFPDNUMICE-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,3-dimethylpyrazol-4-yl)-2-(2-methoxy-5-methylsulfonylphenyl)-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-4-one Chemical compound COC1=CC=C(S(C)(=O)=O)C=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N(C=1C(=NN(C)C=1)C)C2=O QIDDUFPDNUMICE-UHFFFAOYSA-N 0.000 claims 1
- AKRFVBQMRAEMIE-FPCUACJBSA-N C1C[C@@H](OC)CC[C@@H]1N1C(=O)C(C=C(C=2C(=NC(=NC=2)N(C)C)OC)N2C(C)C)=C2C1C1=CC=C(Cl)C=C1 Chemical compound C1C[C@@H](OC)CC[C@@H]1N1C(=O)C(C=C(C=2C(=NC(=NC=2)N(C)C)OC)N2C(C)C)=C2C1C1=CC=C(Cl)C=C1 AKRFVBQMRAEMIE-FPCUACJBSA-N 0.000 claims 1
- IPENFCPRNDWIGT-OPYUEGPBSA-N C1C[C@@H](OC)CC[C@@H]1N1C(=O)C(C=C(C=2C(=NC(OC)=NC=2)OC)N2C(C)C)=C2C1C1=CC=C(Cl)C=C1 Chemical compound C1C[C@@H](OC)CC[C@@H]1N1C(=O)C(C=C(C=2C(=NC(OC)=NC=2)OC)N2C(C)C)=C2C1C1=CC=C(Cl)C=C1 IPENFCPRNDWIGT-OPYUEGPBSA-N 0.000 claims 1
- QTAFEUVFQYQYKE-UHFFFAOYSA-N CN1C(C=C(C=C1)N1C2=C(C=C1)C(NC2)=O)=O Chemical compound CN1C(C=C(C=C1)N1C2=C(C=C1)C(NC2)=O)=O QTAFEUVFQYQYKE-UHFFFAOYSA-N 0.000 claims 1
- KZQDLPAJTPPTAM-TUNMPCEVSA-N CNC(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)[C@@H]2CC[C@@H](O)CC2)C=2C(=CC(Cl)=CC=2)C)C(C)C)=C1 Chemical compound CNC(=O)C1=CC=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)[C@@H]2CC[C@@H](O)CC2)C=2C(=CC(Cl)=CC=2)C)C(C)C)=C1 KZQDLPAJTPPTAM-TUNMPCEVSA-N 0.000 claims 1
- RTAFRPOIUHCUMY-OPYUEGPBSA-N COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N([C@@H]1CC[C@@H](O)CC1)C2=O Chemical compound COC1=NC(N(C)C)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N([C@@H]1CC[C@@H](O)CC1)C2=O RTAFRPOIUHCUMY-OPYUEGPBSA-N 0.000 claims 1
- DKZAVKJTJZOTNQ-IQHDZCMKSA-N COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N([C@@H]1CC[C@@H](O)CC1)C2=O Chemical compound COC1=NC(N)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N([C@@H]1CC[C@@H](O)CC1)C2=O DKZAVKJTJZOTNQ-IQHDZCMKSA-N 0.000 claims 1
- WIGIFXMDHPZEEJ-CIQKOQMRSA-N COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N([C@@H]1CC[C@@H](O)CC1)C2=O Chemical compound COC1=NC(OC)=NC=C1C(N1C(C)C)=CC2=C1C(C=1C=CC(Cl)=CC=1)N([C@@H]1CC[C@@H](O)CC1)C2=O WIGIFXMDHPZEEJ-CIQKOQMRSA-N 0.000 claims 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- HPAAKFMELHCBPC-UHFFFAOYSA-N ethyl 2-[5-[5-(3-chloro-2-fluorophenyl)-6-(4-cyanophenyl)-4-oxo-1-propan-2-yl-6h-pyrrolo[3,4-b]pyrrol-2-yl]-6-methoxypyridin-3-yl]acetate Chemical compound CCOC(=O)CC1=CN=C(OC)C(C=2N(C=3C(N(C(=O)C=3C=2)C=2C(=C(Cl)C=CC=2)F)C=2C=CC(=CC=2)C#N)C(C)C)=C1 HPAAKFMELHCBPC-UHFFFAOYSA-N 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- DOYOPBSXEIZLRE-UHFFFAOYSA-N pyrrole-3-carboxylic acid Natural products OC(=O)C=1C=CNC=1 DOYOPBSXEIZLRE-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261651354P | 2012-05-24 | 2012-05-24 | |
| US61/651,354 | 2012-05-24 | ||
| US201361776052P | 2013-03-11 | 2013-03-11 | |
| US61/776,052 | 2013-03-11 | ||
| PCT/IB2013/054240 WO2013175417A1 (en) | 2012-05-24 | 2013-05-22 | Pyrrolopyrrolidinone compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015517566A JP2015517566A (ja) | 2015-06-22 |
| JP2015517566A5 true JP2015517566A5 (enExample) | 2016-07-07 |
| JP6171003B2 JP6171003B2 (ja) | 2017-07-26 |
Family
ID=48746608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015513334A Expired - Fee Related JP6171003B2 (ja) | 2012-05-24 | 2013-05-22 | ピロロピロリジノン化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9365576B2 (enExample) |
| EP (1) | EP2855483B1 (enExample) |
| JP (1) | JP6171003B2 (enExample) |
| CN (1) | CN104321325B (enExample) |
| AR (1) | AR092838A1 (enExample) |
| TW (1) | TW201400485A (enExample) |
| UY (1) | UY34820A (enExample) |
| WO (1) | WO2013175417A1 (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8440693B2 (en) | 2009-12-22 | 2013-05-14 | Novartis Ag | Substituted isoquinolinones and quinazolinones |
| WO2013080141A1 (en) | 2011-11-29 | 2013-06-06 | Novartis Ag | Pyrazolopyrrolidine compounds |
| UY34591A (es) | 2012-01-26 | 2013-09-02 | Novartis Ag | Compuestos de imidazopirrolidinona |
| EP2855483B1 (en) | 2012-05-24 | 2017-10-25 | Novartis AG | Pyrrolopyrrolidinone compounds |
| US9403827B2 (en) | 2013-01-22 | 2016-08-02 | Novartis Ag | Substituted purinone compounds |
| WO2014115080A1 (en) | 2013-01-22 | 2014-07-31 | Novartis Ag | Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction |
| US8975417B2 (en) | 2013-05-27 | 2015-03-10 | Novartis Ag | Pyrazolopyrrolidine derivatives and their use in the treatment of disease |
| CN105209467B (zh) | 2013-05-27 | 2018-06-08 | 诺华股份有限公司 | 咪唑并吡咯烷酮衍生物及其在治疗疾病中的用途 |
| WO2014191911A1 (en) | 2013-05-28 | 2014-12-04 | Novartis Ag | Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease |
| AU2014272695B2 (en) | 2013-05-28 | 2016-10-20 | Novartis Ag | Pyrazolo-pyrrolidin-4-one derivatives as BET inhibitors and their use in the treatment of disease |
| GB201311888D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201311891D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compound |
| MX2016006667A (es) * | 2013-11-21 | 2016-07-26 | Novartis Ag | Derivados de pirrolo-pirrolona y su uso como inhibidores. |
| CN103724256A (zh) * | 2013-12-13 | 2014-04-16 | 成都丽璟科技有限公司 | 一种合成2-烷氧基-4-取代吡啶类衍生物的方法 |
| US20180228907A1 (en) | 2014-04-14 | 2018-08-16 | Arvinas, Inc. | Cereblon ligands and bifunctional compounds comprising the same |
| JP6817962B2 (ja) | 2015-01-20 | 2021-01-20 | アルビナス・オペレーションズ・インコーポレイテッドＡｒｖｉｎａｓ Ｏｐｅｒａｔｉｏｎｓ， Ｉｎｃ． | ターゲティングされたアンドロゲン受容体分解のための化合物および方法 |
| US12312316B2 (en) | 2015-01-20 | 2025-05-27 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
| WO2016197114A1 (en) | 2015-06-05 | 2016-12-08 | Arvinas, Inc. | Tank-binding kinase-1 protacs and associated methods of use |
| EP3319944A4 (en) | 2015-07-10 | 2019-04-24 | Arvinas, Inc. | MDM2-BASED MODULATORS OF PROTEOLYSIS AND RELATED USE METHODS |
| EP3337476A4 (en) | 2015-08-19 | 2019-09-04 | Arvinas, Inc. | Compounds and methods for the targeted degradation of bromodomain-containing proteins |
| CN109152843A (zh) | 2016-05-20 | 2019-01-04 | 豪夫迈·罗氏有限公司 | Protac抗体缀合物及其使用方法 |
| MX2019005007A (es) | 2016-11-01 | 2019-07-18 | Arvinas Inc | Protac dirigidos a la proteína tau y métodos asociados de uso. |
| IL266842B (en) | 2016-12-01 | 2022-09-01 | Arvinas Operations Inc | History of tetrahydronaphthalene and tetrahydroisoquinoline as estrogen receptor antagonists |
| CN110753693A (zh) | 2016-12-23 | 2020-02-04 | 阿尔维纳斯运营股份有限公司 | Egfr蛋白水解靶向嵌合分子和相关使用方法 |
| US11173211B2 (en) | 2016-12-23 | 2021-11-16 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides |
| US10806737B2 (en) | 2016-12-23 | 2020-10-20 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of fetal liver kinase polypeptides |
| IL325835A (en) | 2016-12-23 | 2026-03-01 | Univ Yale | Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides |
| US11191741B2 (en) | 2016-12-24 | 2021-12-07 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide |
| IL300417A (en) | 2017-01-26 | 2023-04-01 | Arvinas Operations Inc | Bifunctional benzothiophene compounds, preparations containing them and their use in therapy |
| TWI782056B (zh) | 2017-07-14 | 2022-11-01 | 日商鹽野義製藥股份有限公司 | 具有ｍｇａｔ２抑制活性的縮合環衍生物 |
| US11065231B2 (en) | 2017-11-17 | 2021-07-20 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides |
| EA202091583A1 (ru) * | 2017-12-29 | 2020-10-08 | Ган Энд Ли Фармасьютикалз | Соединения, которые могут применяться в качестве ингибитора опухоли, способ их получения и их применение |
| US11639355B2 (en) | 2018-03-12 | 2023-05-02 | Luoxin Pharmaceutical (Shanghai) Co., Ltd. | Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors |
| BR112020020307A2 (pt) | 2018-04-04 | 2021-01-12 | Arvinas Operations, Inc. | Moduladores de proteólise e métodos de uso associados |
| US11707452B2 (en) | 2018-08-20 | 2023-07-25 | Arvinas Operations, Inc. | Modulators of alpha-synuclein proteolysis and associated methods of use |
| MX2021008050A (es) | 2019-01-11 | 2021-08-05 | Shionogi & Co | Derivado de dihidropirazolopirazinona que tiene actividad inhibidora de monoacilglicerol aciltransferasa 2 (mgat2). |
| US10610280B1 (en) | 2019-02-02 | 2020-04-07 | Ayad K. M. Agha | Surgical method and apparatus for destruction and removal of intraperitoneal, visceral, and subcutaneous fat |
| WO2021041348A1 (en) | 2019-08-26 | 2021-03-04 | Arvinas Operations, Inc. | Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders |
| WO2022047145A1 (en) | 2020-08-28 | 2022-03-03 | Arvinas Operations, Inc. | Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of use |
| AU2021342287A1 (en) | 2020-09-14 | 2023-04-13 | Arvinas Operations, Inc. | Crystalline forms of a compound for the targeted degradation of estrogen receptor |
| CN112876409A (zh) * | 2021-01-20 | 2021-06-01 | 都创(上海)医药科技股份有限公司 | 一种2-(5-溴-6-甲氧基吡啶-2-基)乙腈及其衍生物的合成方法 |
| CN112898200A (zh) * | 2021-01-20 | 2021-06-04 | 都创(上海)医药科技股份有限公司 | 5-溴-6-甲氧基吡啶-2-羧酸酯的合成方法 |
| WO2022183006A1 (en) | 2021-02-25 | 2022-09-01 | Mayo Foundation For Medical Education And Research | Compounds for programmable protein degradation and methods of use for the disease treatment |
| WO2023056069A1 (en) | 2021-09-30 | 2023-04-06 | Angiex, Inc. | Degrader-antibody conjugates and methods of using same |
| EP4584258A1 (en) | 2022-09-07 | 2025-07-16 | Arvinas Operations, Inc. | Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use |
| PE20260006A1 (es) | 2023-01-26 | 2026-01-06 | Arvinas Operations Inc | Protacs degradadores de kras basados en cereblon y usos relacionados con los mismos |
| WO2024240858A1 (en) | 2023-05-23 | 2024-11-28 | Valerio Therapeutics | Protac molecules directed against dna damage repair system and uses thereof |
Family Cites Families (122)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR901228A (fr) | 1943-01-16 | 1945-07-20 | Deutsche Edelstahlwerke Ag | Système d'aimant à entrefer annulaire |
| US3829420A (en) | 1970-07-13 | 1974-08-13 | Sumitomo Chemical Co | 3,4-dihydro-2(1h)-quinazolinones and preparation thereof |
| US4099002A (en) | 1970-12-23 | 1978-07-04 | Sumitomo Chemical Company, Limited | Quinazolinone derivatives and a process for production thereof |
| JPS4822715B1 (enExample) | 1970-12-28 | 1973-07-07 | ||
| JPS5427356B2 (enExample) | 1972-03-31 | 1979-09-10 | ||
| GB1524747A (en) | 1976-05-11 | 1978-09-13 | Ici Ltd | Polypeptide |
| US4258187A (en) | 1977-06-16 | 1981-03-24 | E. I. Du Pont De Nemours And Company | Process for preparing quinazolinone oxides |
| US4335127A (en) | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
| JPS5721388A (en) | 1980-07-11 | 1982-02-04 | Nippon Nohyaku Co Ltd | Condensed pyrazole derivative |
| DE3372965D1 (en) | 1982-07-23 | 1987-09-17 | Ici Plc | Amide derivatives |
| GB8327256D0 (en) | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
| DE3420799A1 (de) | 1984-06-04 | 1985-12-05 | Bayer Ag, 5090 Leverkusen | Chromogene 4,4-diaryl-dihydrochinazolone, ihre herstellung und verwendung |
| US5093330A (en) | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
| US5010099A (en) | 1989-08-11 | 1991-04-23 | Harbor Branch Oceanographic Institution, Inc. | Discodermolide compounds, compositions containing same and method of preparation and use |
| US5395855A (en) | 1990-05-07 | 1995-03-07 | Ciba-Geigy Corporation | Hydrazones |
| NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
| WO1993004047A1 (en) | 1991-08-16 | 1993-03-04 | Merck & Co., Inc. | Quinazoline derivatives as inhibitors of hiv reverse transcriptase |
| AU661533B2 (en) | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
| TW225528B (enExample) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
| KR100335584B1 (ko) | 1992-10-28 | 2002-11-29 | 제넨테크, 인코포레이티드 | 혈관내피세포성장인자에대한길항제 |
| GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
| US5508300A (en) | 1994-01-14 | 1996-04-16 | Pfizer Inc. | Dihydro pyrazolopyrroles, compositions and use |
| ATE446955T1 (de) | 1995-03-30 | 2009-11-15 | Pfizer Prod Inc | Chinazolinone derivate |
| GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
| US5880141A (en) | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
| US5843901A (en) | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
| PL188959B1 (pl) | 1995-07-06 | 2005-05-31 | Novartis Ag | Pirolopirymidyny i sposoby ich wytwarzania |
| US5760041A (en) | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
| GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| CN100503580C (zh) | 1996-04-12 | 2009-06-24 | 沃尼尔·朗伯公司 | 酪氨酸激酶的不可逆抑制剂 |
| BR9709959A (pt) | 1996-06-24 | 2000-05-09 | Pfizer | Derivados tricìclicos de fenilamino substituìdo para o tratamento de doenças hiperproliferativas |
| EP0958305B1 (en) | 1996-07-05 | 2008-06-04 | Cancer Research Technology Limited | Inhibitions of the interaction between p53 and mdm2 |
| AU716610B2 (en) | 1996-08-30 | 2000-03-02 | Novartis Ag | Method for producing epothilones, and intermediate products obtained during the production process |
| DE938597T1 (de) | 1996-09-06 | 2000-03-09 | Obducat Ab | Verfahren für das anisotrope ätzen von strukturen in leitende materialien |
| DE19638745C2 (de) | 1996-09-11 | 2001-05-10 | Schering Ag | Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) |
| WO1998010767A2 (en) | 1996-09-13 | 1998-03-19 | Sugen, Inc. | Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
| EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
| EP0882314B1 (en) | 1996-10-28 | 1999-10-06 | Abb Power Systems Ab | Sea electrode for a high voltage direct current transmission system |
| ATE267197T1 (de) | 1996-11-18 | 2004-06-15 | Biotechnolog Forschung Gmbh | Epothilon d, dessen herstellung und dessen verwendung als cytostatisches mittel bzw. als pflanzenschutzmittel |
| US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
| CO4950519A1 (es) | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
| HRP980143A2 (en) | 1997-04-09 | 1999-02-28 | Soo Sung Ko | 4,4-disubstituted-3,4-dihydro-2 (1h)-quinazolinones useful as hiv reverse transcriptase inhibitors |
| CO4940418A1 (es) | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
| GB9721069D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
| US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
| CA2322157C (en) | 1998-02-25 | 2012-05-29 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| ES2342240T3 (es) | 1998-08-11 | 2010-07-02 | Novartis Ag | Derivados de isoquinolina con actividad que inhibe la angiogenia. |
| UA71587C2 (uk) | 1998-11-10 | 2004-12-15 | Шерінг Акцієнгезелльшафт | Аміди антранілової кислоти та їхнє застосування як лікарських засобів |
| GB9824579D0 (en) | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
| CN100381566C (zh) | 1998-11-20 | 2008-04-16 | 科森生物科学公司 | 产生环氧噻酮及其衍生物的重组方法和材料 |
| EP1579871A1 (en) | 1998-12-22 | 2005-09-28 | Genentech, Inc. | Vascular endothelial cell growth factor antagonists and uses thereof |
| ATE329596T1 (de) | 1999-03-30 | 2006-07-15 | Novartis Pharma Gmbh | Phthalazinderivate zur behandlung von entzündlicher erkrankungen |
| DE19918211A1 (de) * | 1999-04-22 | 2000-10-26 | Basf Ag | Cycloalkylsubstituierte Benzimidazole, deren Herstellung und Anwendung |
| WO2000066560A1 (en) | 1999-05-04 | 2000-11-09 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| JP2001302515A (ja) | 2000-04-18 | 2001-10-31 | Sumitomo Pharmaceut Co Ltd | ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤 |
| US6479499B1 (en) | 2000-06-28 | 2002-11-12 | National Science Council | 2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions |
| CA2416527C (en) | 2000-08-10 | 2009-12-22 | Pharmacia Italia S.P.A. | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
| TWI238824B (en) | 2001-05-14 | 2005-09-01 | Novartis Ag | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives |
| GB0119249D0 (en) | 2001-08-07 | 2001-10-03 | Novartis Ag | Organic compounds |
| KR100650966B1 (ko) | 2001-12-18 | 2006-11-30 | 에프. 호프만-라 로슈 아게 | 시스-2,4,5-트리페닐-이미다졸린 및 종양 치료에서의 그의용도 |
| CA2473740A1 (en) | 2002-01-18 | 2003-07-31 | David Solow-Cordero | Methods of treating conditions associated with an edg receptor |
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| US20060189511A1 (en) | 2002-05-13 | 2006-08-24 | Koblish Holly K | Method for cytoprotection through mdm2 and hdm2 inhibition |
| US7119111B2 (en) | 2002-05-29 | 2006-10-10 | Amgen, Inc. | 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| AU2003253165A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
| US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US20040214856A1 (en) | 2003-04-23 | 2004-10-28 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US20040213264A1 (en) | 2003-04-25 | 2004-10-28 | Nortel Networks Limited | Service class and destination dominance traffic management |
| WO2005019188A1 (ja) | 2003-08-22 | 2005-03-03 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
| AU2004273610B2 (en) | 2003-09-22 | 2010-07-01 | Onepharm Research & Development Gmbh | Prevention and treatment of inflammation-induced and/or immune-mediated bone loss |
| SI1689724T1 (sl) | 2003-11-25 | 2012-04-30 | Novartis Ag | Spojine kinazolinona kot sredstva proti raku |
| KR20080027969A (ko) | 2004-05-18 | 2008-03-28 | 에프. 호프만-라 로슈 아게 | 신규 ｃｉｓ-이미다졸린 |
| WO2005117876A1 (en) | 2004-06-01 | 2005-12-15 | University Of Virginia Patent Foundation | Dual small molecule inhibitors of cancer and angiogenesis |
| GB0419481D0 (en) | 2004-09-02 | 2004-10-06 | Cancer Rec Tech Ltd | Isoindolin-1-one derivatives |
| US20060069085A1 (en) | 2004-09-28 | 2006-03-30 | Rulin Zhao | Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| WO2006074262A1 (en) | 2005-01-05 | 2006-07-13 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
| EP1868685A2 (en) | 2005-03-18 | 2007-12-26 | onepharm GmbH | 11ß-HYDROXYSTEROID DEHYDROGENASES |
| AR056285A1 (es) | 2005-03-23 | 2007-10-03 | Syngenta Participations Ag | Derivados de triazolopirimidina y composiciones fungicidas |
| US7576082B2 (en) | 2005-06-24 | 2009-08-18 | Hoffman-La Roche Inc. | Oxindole derivatives |
| WO2007068637A1 (en) | 2005-12-12 | 2007-06-21 | Nerviano Medical Sciences S.R.L. | Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors |
| WO2007096334A1 (en) | 2006-02-24 | 2007-08-30 | Pfizer Italia Srl | Pyrrolopyrrolones active as kinase inhibitors |
| DE102006016426A1 (de) | 2006-04-07 | 2007-10-11 | Merck Patent Gmbh | Neuartige Cyclobutyl-Verbindungen als Kinase-Inhibitoren |
| WO2007144384A1 (en) | 2006-06-14 | 2007-12-21 | 4Sc Ag | Pyrazolopyrimidones |
| US8222288B2 (en) | 2006-08-30 | 2012-07-17 | The Regents Of The University Of Michigan | Small molecule inhibitors of MDM2 and the uses thereof |
| WO2008034039A2 (en) | 2006-09-15 | 2008-03-20 | Nexuspharma Inc. | Novel tetrahydro-isoquinolines |
| JP2010504933A (ja) * | 2006-09-29 | 2010-02-18 | ノバルティス アーゲー | Ｐｉ３ｋ脂質キナーゼ阻害剤としてのピラゾロピリミジン |
| WO2008045529A1 (en) | 2006-10-12 | 2008-04-17 | Serenex, Inc. | Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases |
| TW200843739A (en) | 2007-03-30 | 2008-11-16 | Shionogi & Co | Novel pyrrolinone derivative and composition containing the same |
| WO2008130614A2 (en) | 2007-04-20 | 2008-10-30 | University Of Pittsburg-Of The Commonwealth System Of Higher Education | Selective and dual-action p53/mdm2/mdm4 antagonists |
| AU2008345225A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| AU2009259853A1 (en) * | 2008-06-20 | 2009-12-23 | Genentech, Inc. | Triazolopyridine JAK inhibitor compounds and methods |
| UY31982A (es) | 2008-07-16 | 2010-02-26 | Boehringer Ingelheim Int | Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas |
| JP5637562B2 (ja) | 2008-09-25 | 2014-12-10 | 塩野義製薬株式会社 | 新規ピロリノン誘導体およびそれを含有する医薬組成物 |
| WO2010047956A1 (en) | 2008-10-08 | 2010-04-29 | Bristol-Myers Squibb Company | Azolopyrrolone melanin concentrating hormone receptor-1 antagonists |
| RU2016116516A (ru) | 2008-12-08 | 2018-12-07 | Мандифарма Интернэшнл Корпорейшн Лимитед | Композиции ингибиторов тирозинкиназных рецепторов белков |
| WO2010141738A2 (en) | 2009-06-03 | 2010-12-09 | President And Fellows Of Harvard College | Compositions and method for inhibiting tumor growth |
| EA201200321A1 (ru) * | 2009-08-26 | 2012-09-28 | Новартис Аг | Тетразамещенные гетероарильные соединения и их применение в качестве модуляторов mdm2 и/или mdm4 |
| US8440693B2 (en) | 2009-12-22 | 2013-05-14 | Novartis Ag | Substituted isoquinolinones and quinazolinones |
| EP2585465B1 (en) | 2010-06-22 | 2014-11-12 | GlaxoSmithKline LLC | Benzotriazolodiazepine compounds inhibitors of bromodomains |
| US20120065210A1 (en) | 2010-09-15 | 2012-03-15 | Xin-Jie Chu | Substituted hexahydropyrrolo[1,2-c]imidazolones |
| GB201016880D0 (en) | 2010-10-07 | 2010-11-17 | Riotech Pharmaceuticals Ltd | Phosphodiesterase inhibitors |
| PE20140408A1 (es) | 2010-11-12 | 2014-04-10 | Univ Michigan | Derivados espiro-oxindol como antagonistas de mdm2 |
| SI2640467T1 (sl) | 2010-11-19 | 2015-04-30 | Novartis Ag | Kristalinična oblika inhibitorja interakcije MDM2/4 in P53 |
| WO2012151512A2 (en) | 2011-05-04 | 2012-11-08 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| WO2012174487A2 (en) | 2011-06-17 | 2012-12-20 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| EP2721007B1 (en) | 2011-06-20 | 2015-04-29 | Novartis AG | Cyclohexyl isoquinolinone compounds |
| EP2721008B1 (en) | 2011-06-20 | 2015-04-29 | Novartis AG | Hydroxy substituted isoquinolinone derivatives as p53 (mdm2 or mdm4) inhibitors |
| WO2013027168A1 (en) | 2011-08-22 | 2013-02-28 | Pfizer Inc. | Novel heterocyclic compounds as bromodomain inhibitors |
| WO2013033268A2 (en) | 2011-08-29 | 2013-03-07 | Coferon, Inc. | Bivalent bromodomain ligands, and methods of using same |
| WO2013080141A1 (en) | 2011-11-29 | 2013-06-06 | Novartis Ag | Pyrazolopyrrolidine compounds |
| WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
| UY34591A (es) | 2012-01-26 | 2013-09-02 | Novartis Ag | Compuestos de imidazopirrolidinona |
| US20130281396A1 (en) | 2012-04-19 | 2013-10-24 | Rvx Therapeutics Inc. | Treatment of diseases by epigenetic regulation |
| US20130281397A1 (en) | 2012-04-19 | 2013-10-24 | Rvx Therapeutics Inc. | Treatment of diseases by epigenetic regulation |
| US20130281399A1 (en) | 2012-04-19 | 2013-10-24 | Rvx Therapeutics Inc. | Treatment of diseases by epigenetic regulation |
| WO2013155695A1 (en) | 2012-04-20 | 2013-10-24 | Abbott Laboratories | Isoindolone derivatives |
| EP2855483B1 (en) | 2012-05-24 | 2017-10-25 | Novartis AG | Pyrrolopyrrolidinone compounds |
| US9403827B2 (en) | 2013-01-22 | 2016-08-02 | Novartis Ag | Substituted purinone compounds |
| WO2014115080A1 (en) | 2013-01-22 | 2014-07-31 | Novartis Ag | Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction |
| US8975417B2 (en) | 2013-05-27 | 2015-03-10 | Novartis Ag | Pyrazolopyrrolidine derivatives and their use in the treatment of disease |
-
2013
- 2013-05-22 EP EP13734183.0A patent/EP2855483B1/en not_active Not-in-force
- 2013-05-22 US US13/900,061 patent/US9365576B2/en not_active Expired - Fee Related
- 2013-05-22 WO PCT/IB2013/054240 patent/WO2013175417A1/en not_active Ceased
- 2013-05-22 JP JP2015513334A patent/JP6171003B2/ja not_active Expired - Fee Related
- 2013-05-22 CN CN201380026322.7A patent/CN104321325B/zh not_active Expired - Fee Related
- 2013-05-23 TW TW102118267A patent/TW201400485A/zh unknown
- 2013-05-23 UY UY0001034820A patent/UY34820A/es not_active Application Discontinuation
- 2013-05-24 AR ARP130101812A patent/AR092838A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016520116A5 (enExample) | ||
| JP2016537384A5 (enExample) | ||
| RU2015139590A (ru) | ИНГИБИРУЮЩЕЕ Trk СОЕДИНЕНИЕ | |
| RU2424242C2 (ru) | Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1 | |
| JP2014505735A5 (enExample) | ||
| JP2012501312A5 (enExample) | ||
| JP2014526549A5 (enExample) | ||
| RU2006136881A (ru) | Фармацевтическая композиция, содержащая производное бензодиазепина и ингибитор белка слияния rsv | |
| JP2020504136A5 (enExample) | ||
| JP2014526501A5 (enExample) | ||
| JP2021503458A5 (enExample) | ||
| RU2016129953A (ru) | Фармацевтические комбинации | |
| RU2018110770A (ru) | Ингибиторы mdm2 и их комбинации | |
| RU2018112237A (ru) | Новые бициклические соединения в качестве дуальных ингибиторов atx/ca | |
| CA2789665A1 (en) | Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases | |
| RU2015154676A (ru) | Соединения для лечения спинальной мышечной атрофии | |
| RU2016127623A (ru) | Производные бензотриазола в качестве модуляторов активности tnf | |
| JP2017535561A5 (enExample) | ||
| JP2015508749A5 (enExample) | ||
| RU2015120216A (ru) | Ингибиторы тирозинкиназы брутона | |
| JP2013543896A5 (enExample) | ||
| JP2017528487A5 (enExample) | ||
| JP2012519693A5 (enExample) | ||
| JP2017537949A5 (enExample) | ||
| RU2018104702A (ru) | Новые соединения пирролопиримидина в качестве ингибиторов протеинкиназ |